Commerzbank Aktiengesellschaft’s VolitionRx Ltd VNRX Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio VNRX Stock Details VNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-575	Closed	-$45K	–	1182
2015 Q2	$45K	Hold	575	–	–	﹤0.01%	1170
2015 Q1	$47K	Buy	+575	New	+$47.6K	﹤0.01%	1134

Other funds holding VNRX

SCA

Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GBA

Garrison Bradford & Associates New York $88.4M AUM 15.86% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commerzbank Aktiengesellschaft's VNRX Position: Q3 2015 in Review

Commerzbank Aktiengesellschaft sold out of VolitionRx Ltd (VNRX) in Q3 2015, closing a stake of 575 shares — an estimated $45K sold.

Commerzbank Aktiengesellschaft first reported a position in VNRX in Q1 2015 and held it in 2 quarters. The position peaked at $47K in Q1 2015. 9 funds tracked by Wall St. Rank hold VNRX as of Q3 2015.

Commerzbank Aktiengesellschaft reported no remaining VolitionRx Ltd position as of Q3 2015 after selling out during the quarter.
Commerzbank Aktiengesellschaft sold 575 VolitionRx Ltd shares in Q3 2015, an estimated $45K.
Commerzbank Aktiengesellschaft first reported a position in VolitionRx Ltd in Q1 2015 and held it in 2 quarters.
Commerzbank Aktiengesellschaft's VolitionRx Ltd position peaked at $47K in Q1 2015.
9 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q3 2015.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q3 2015, filed 29 Oct 2015.